| Ipsen Pharma Schweiz GmbH - Relfydess 150 units/ 1,5 ml, Injektionslösung | | 69620 | | 01 | | Relfydess 150 units/ 1,5 ml | | Injektionslösung | | M03AX01 | | Botulinum Toxin | | 10.03.2025 | | |
| | Composition | | toxinum botulinicum A (stirpis I01) 150 U., dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, kalii chloridum, natrii chloridum, polysorbatum 80, tryptophanum, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 5.4 mg et kalium 0.18 mg. | | Packungsbestandteile | | Injection solution | | | | | | Active Agent | Dose |
|---|
| Toxinum Botulinicum a (Stirpis I01) | 150U. / 1.5ml |
| | | | Inactive agents |
|---|
| Disodium Phosphate Dihydrate | | Potassium Chloride | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Polysorbatum 80 | | Tryptophan |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | No | | 002 | 10 | PR | PR | A | | No |
|
|
